Cme Group annual ebitda
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group EBITDA Growth & History (CME)
Cme Group's calculated EBITDA was $4.34B for fiscal 2025.
View full Cme Group company overviewCme Group annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.34B | $290.4M | +7.18% |
| 2024 | 2024-12-31 | $4.05B | $484.9M | +13.61% |
| 2023 | 2023-12-31 | $3.56B | $410.9M | +13.04% |
| 2022 | 2022-12-31 | $3.15B | $357.8M | +12.81% |
| 2021 | 2021-12-31 | $2.79B | $2.4M | +0.09% |
| 2020 | 2020-12-31 | $2.79B | $44.2M | +1.61% |
| 2019 | 2019-12-31 | $2.75B | $20.1M | +0.74% |
| 2018 | 2018-12-31 | $2.73B | $302.7M | +12.49% |
| 2017 | 2017-12-31 | $2.42B | $93.9M | +4.03% |
| 2016 | 2016-12-31 | $2.33B | $211.8M | +10.00% |
| 2015 | 2015-12-31 | $2.12B | $216.9M | +11.41% |
| 2014 | 2014-12-31 | $1.90B | $128.9M | +7.27% |
| 2013 | 2013-12-31 | $1.77B | −$56.8M | −3.11% |
| 2012 | 2012-12-31 | $1.83B | −$320.7M | −14.92% |
| 2011 | 2011-12-31 | $2.15B | $188.6M | +9.62% |
| 2010 | 2010-12-31 | $1.96B | $245.6M | +14.32% |
| 2009 | 2009-12-31 | $1.72B | −$4.1M | −0.24% |
| 2008 | 2008-12-31 | $1.72B | $561.9M | +48.54% |
| 2007 | 2007-12-31 | $1.16B | — | — |
Cme Group quarterly ebitda
Q2.08
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.19B | −$21.4M | −1.76% |
| Q1 2026 | 2026-03-31 | $1.39B | $202.5M | +17.01% |
| Q4 2025 | 2025-12-31 | $878.6M | $69.8M | +8.63% |
| Q3 2025 | 2025-09-30 | $1.06B | −$52.9M | −4.77% |
| Q2 2025 | 2025-06-30 | $1.21B | $127.9M | +11.79% |
| Q1 2025 | 2025-03-31 | $1.19B | $145.6M | +13.93% |
| Q4 2024 | 2024-12-31 | $808.8M | $85.9M | +11.88% |
| Q3 2024 | 2024-09-30 | $1.11B | $199.6M | +21.97% |
| Q2 2024 | 2024-06-30 | $1.08B | $156.9M | +16.91% |
| Q1 2024 | 2024-03-31 | $1.04B | $42.5M | +4.24% |
| Q4 2023 | 2023-12-31 | $722.9M | $191.7M | +36.09% |
| Q3 2023 | 2023-09-30 | $908.5M | $79.7M | +9.62% |
| Q2 2023 | 2023-06-30 | $927.9M | $88.1M | +10.49% |
| Q1 2023 | 2023-03-31 | $1.00B | $51.4M | +5.40% |
| Q4 2022 | 2022-12-31 | $531.2M | $42.6M | +8.72% |
| Q3 2022 | 2022-09-30 | $828.8M | $118.9M | +16.75% |
| Q2 2022 | 2022-06-30 | $839.8M | $68.6M | +8.90% |
| Q1 2022 | 2022-03-31 | $951.0M | $127.7M | +15.51% |
| Q4 2021 | 2021-12-31 | $488.6M | $164.3M | +50.66% |
| Q3 2021 | 2021-09-30 | $709.9M | $66.9M | +10.40% |
| Q2 2021 | 2021-06-30 | $771.2M | $20.4M | +2.72% |
| Q1 2021 | 2021-03-31 | $823.3M | −$249.2M | −23.24% |
| Q4 2020 | 2020-12-31 | $324.3M | −$286.7M | −46.92% |
| Q3 2020 | 2020-09-30 | $643.0M | −$83.6M | −11.51% |
| Q2 2020 | 2020-06-30 | $750.8M | $5.9M | +0.79% |
| Q1 2020 | 2020-03-31 | $1.07B | $408.6M | +61.55% |
| Q4 2019 | 2019-12-31 | $611.0M | −$71.8M | −10.52% |
| Q3 2019 | 2019-09-30 | $726.6M | $146.5M | +25.25% |
| Q2 2019 | 2019-06-30 | $744.9M | $50.5M | +7.27% |
| Q1 2019 | 2019-03-31 | $663.9M | −$105.1M | −13.67% |
| Q4 2018 | 2018-12-31 | $682.8M | $118.0M | +20.89% |
| Q3 2018 | 2018-09-30 | $580.1M | −$14.4M | −2.42% |
| Q2 2018 | 2018-06-30 | $694.4M | $60.4M | +9.53% |
| Q1 2018 | 2018-03-31 | $769.0M | $138.7M | +22.01% |
| Q4 2017 | 2017-12-31 | $564.8M | −$6.9M | −1.21% |
| Q3 2017 | 2017-09-30 | $594.5M | $38.0M | +6.83% |
| Q2 2017 | 2017-06-30 | $634.0M | $40.3M | +6.79% |
| Q1 2017 | 2017-03-31 | $630.3M | $22.5M | +3.70% |
| Q4 2016 | 2016-12-31 | $571.7M | $70.1M | +13.98% |
| Q3 2016 | 2016-09-30 | $556.5M | $7.7M | +1.40% |
| Q2 2016 | 2016-06-30 | $593.7M | $65.3M | +12.36% |
| Q1 2016 | 2016-03-31 | $607.8M | $68.7M | +12.74% |
| Q4 2015 | 2015-12-31 | $501.6M | −$1.4M | −0.28% |
| Q3 2015 | 2015-09-30 | $548.8M | $85.7M | +18.51% |
| Q2 2015 | 2015-06-30 | $528.4M | $82.1M | +18.40% |
| Q1 2015 | 2015-03-31 | $539.1M | $50.5M | +10.34% |
| Q4 2014 | 2014-12-31 | $503.0M | $145.5M | +40.70% |
| Q3 2014 | 2014-09-30 | $463.1M | $27.6M | +6.34% |
| Q2 2014 | 2014-06-30 | $446.3M | −$94.7M | −17.50% |
| Q1 2014 | 2014-03-31 | $488.6M | $50.5M | +11.53% |
| Q4 2013 | 2013-12-31 | $357.5M | −$52.0M | −12.70% |
| Q3 2013 | 2013-09-30 | $435.5M | $5.0M | +1.16% |
| Q2 2013 | 2013-06-30 | $541.0M | $38.2M | +7.60% |
| Q1 2013 | 2013-03-31 | $438.1M | −$48.0M | −9.87% |
| Q4 2012 | 2012-12-31 | $409.5M | −$14.3M | −3.37% |
| Q3 2012 | 2012-09-30 | $430.5M | −$174.0M | −28.78% |
| Q2 2012 | 2012-06-30 | $502.8M | −$63.4M | −11.20% |
| Q1 2012 | 2012-03-31 | $486.1M | −$69.0M | −12.43% |
| Q4 2011 | 2011-12-31 | $423.8M | −$66.4M | −13.55% |
| Q3 2011 | 2011-09-30 | $604.5M | $128.5M | +27.00% |
| Q2 2011 | 2011-06-30 | $566.2M | $18.3M | +3.34% |
| Q1 2011 | 2011-03-31 | $555.1M | $108.2M | +24.21% |
| Q4 2010 | 2010-12-31 | $490.2M | $54.8M | +12.59% |
| Q3 2010 | 2010-09-30 | $476.0M | $42.3M | +9.75% |
| Q2 2010 | 2010-06-30 | $547.9M | $119.0M | +27.75% |
| Q1 2010 | 2010-03-31 | $446.9M | $29.5M | +7.07% |
| Q4 2009 | 2009-12-31 | $435.4M | — | — |
| Q3 2009 | 2009-09-30 | $433.7M | −$21.1M | −4.64% |
| Q2 2009 | 2009-06-30 | $428.9M | $50.7M | +13.41% |
| Q1 2009 | 2009-03-31 | $417.4M | — | — |
| Q3 2008 | 2008-09-30 | $454.8M | — | — |
| Q2 2008 | 2008-06-30 | $378.2M | — | — |
Cme Group ebitda trends
Over the last five fiscal years, Cme Group's ebitda increased from $2.79B to $4.34B, a change of $1.55B. The latest reported quarter, Q2 2026, shows $1.19B.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...
